Battered King picks new CFO after months of questions
King Pharmaceuticals appointed Joseph Squicciarino chief financial officer.
News of the former Revlon CFO's appointment buoyed the troubled company's stocks, battered in recent months by a botched merger and questions over past earnings statements. A bid by Mylan Laboratories to acquire King was scuttled in February after the Bristol, Tenn.-based company said it would have to restate earnings results from 2002 through the first half of 2004. Squicciarino, who worked for
Johnson & Johnson and Bristol- Myers Squibb before joining Revlon, succeeds James Lattanzi, whose retirement was announced in April.